| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0021-9150(98)00174-9 |
| P698 | PubMed publication ID | 9862182 |
| P2093 | author name string | P J Schreiner | |
| P N Hopkins | |||
| R R Williams | |||
| S C Hunt | |||
| I B Borecki | |||
| J H Eckfeldt | |||
| K D Siegmund | |||
| C R Ellison | |||
| P2860 | cites work | Activation of transforming growth factor-beta is inhibited in transgenic apolipoprotein(a) mice | Q24315861 |
| Lipoprotein[a] as a risk factor for preclinical atherosclerosis | Q28269392 | ||
| Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia | Q28307248 | ||
| Elevated serum lipoprotein(a) is a risk factor for clinical recurrence after coronary balloon angioplasty | Q30465479 | ||
| Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men. | Q35171679 | ||
| Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease | Q35599857 | ||
| Close relation between lipoprotein (a) levels and atherothrombotic disease in Japanese subjects > 75 years of age | Q72516241 | ||
| Rapid angiographic progression of coronary artery disease in patients with elevated lipoprotein(a) | Q72533079 | ||
| Relation of coronary artery disease in women < 60 years of age to the combined elevation of serum lipoprotein (a) and total cholesterol to high-density cholesterol ratio | Q72646524 | ||
| Apolipoproteins and ischaemic heart disease: implications for screening | Q72662515 | ||
| A prospective investigation of elevated lipoprotein (a) detected by electrophoresis and cardiovascular disease in women. The Framingham Heart Study | Q72711421 | ||
| Association of elevated lipoprotein(a) levels and coronary heart disease in NIDDM patients. Relationship with apolipoprotein(a) phenotypes | Q72717812 | ||
| Plasma Lp(a) levels correlate with number, severity, and length-extension of coronary lesions in male patients undergoing coronary arteriography for clinically suspected coronary atherosclerosis | Q72773125 | ||
| The relationship between serum lipoprotein(a) and restenosis after initial elective percutaneous transluminal coronary angioplasty | Q72889432 | ||
| Lipoprotein(a) as a determinant of coronary heart disease in young women | Q73012588 | ||
| Apolipoprotein(a) attenuates endogenous fibrinolysis in the rabbit jugular vein thrombosis model in vivo | Q73744448 | ||
| Apolipoprotein(a) induces monocyte chemotactic activity in human vascular endothelial cells | Q73841615 | ||
| Lipoprotein(a) interactions with lipid and nonlipid risk factors in early familial coronary artery disease | Q73965827 | ||
| [Rapid physiological coagulation method in determination of fibrinogen] | Q74515389 | ||
| Lipoprotein (a) inhibits the generation of transforming growth factor beta: an endogenous inhibitor of smooth muscle cell migration | Q36529887 | ||
| Serum lipoprotein(a) concentrations are related to coronary disease progression without new myocardial infarction | Q36824175 | ||
| The atherogenic lipoprotein Lp(a) is internalized and degraded in a process mediated by the VLDL receptor | Q37374146 | ||
| Genomic instability in the type II TGF-beta1 receptor gene in atherosclerotic and restenotic vascular cells | Q37374163 | ||
| Dose-response relationships of serum lipid measurements with the extent of coronary stenosis. Strong, independent, and comprehensive. ECAT Angina Pectoris Study Group | Q38913680 | ||
| Lipoprotein (a) and coronary heart disease. | Q40479993 | ||
| Predictive value of electrophoretically detected lipoprotein(a) for coronary heart disease and cerebrovascular disease in a community-based cohort of 9936 men and women | Q40881466 | ||
| NHLBI Family Heart Study: objectives and design | Q40936323 | ||
| Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants | Q41148759 | ||
| A comparison of positive family history definitions for defining risk of future disease | Q41362772 | ||
| Antifibrinolytic activity of apolipoprotein(a) in vivo: Human apolipoprotein(a) transgenic mice are resistant to tissue plasminogen activator-mediated thrombolysis | Q41671750 | ||
| Familial lipoprotein disorders in patients with premature coronary artery disease | Q43750570 | ||
| Serum Lp(a) as a discriminant marker of early atherosclerotic plaque at three extracoronary sites in hypercholesterolemic men. The PCVMETRA Group | Q44517840 | ||
| Lipoprotein(a), fibrin binding, and plasminogen activation. | Q46032840 | ||
| Relation of plasma lipoprotein(a) to infarct artery patency in survivors of myocardial infarction | Q46704669 | ||
| A prospective case-control study of lipoprotein(a) levels and apo(a) size and risk of coronary heart disease in Stanford Five-City Project participants | Q47314597 | ||
| Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS). | Q48754609 | ||
| Lipoprotein(a) and accelerated coronary artery disease in cardiac transplant recipients | Q50541260 | ||
| Lack of increased coronary atherosclerotic risk due to elevated lipoprotein(a) in women > or = 55 years of age. | Q51007599 | ||
| Apolipoprotein(a) kringle IV repeat number predicts risk for coronary heart disease. | Q51031934 | ||
| Race and gender differences in the association of Lp(a) with carotid artery wall thickness. The Atherosclerosis Risk in Communities (ARIC) Study. | Q51033197 | ||
| Plasma Lp(a), apolipoprotein(a) isoforms and acute myocardial infarction in men and women: a case-control study in the Jerusalem population. | Q51061066 | ||
| Lipoprotein(a) and acute-phase proteins in acute myocardial infarction | Q51606314 | ||
| The relationship between serum levels of lipoprotein(a) and proteins associated with the acute phase response. | Q52386658 | ||
| Lipoprotein cholesterol, apolipoprotein A-I and B and lipoprotein (a) abnormalities in men with premature coronary artery disease. | Q52861239 | ||
| Haemostatic factors and prevalent coronary heart disease; the FINRISK Haemostasis Study. | Q53688840 | ||
| Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study | Q57337243 | ||
| Lipoprotein(a) is an independent risk factor for cardiovascular disease in hemodialysis patients | Q67546017 | ||
| Oxidation of lipoprotein Lp(a). A comparison with low-density lipoproteins | Q67897493 | ||
| Lipoprotein(a) impairs generation of plasmin by fibrin-bound tissue-type plasminogen activator. In vitro studies in a plasma milieu | Q67899309 | ||
| Usefulness of serum lipoprotein (a) as a predictor of restenosis after percutaneous transluminal coronary angioplasty | Q68053733 | ||
| Predictive value of apolipoproteins in a prospective survey of coronary artery disease in men | Q68125221 | ||
| Transient changes of serum lipoprotein(a) as an acute phase protein | Q69102353 | ||
| The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels | Q70021110 | ||
| Interaction of lipoprotein Lp(a) and low density lipoprotein with glycosaminoglycans from human aorta | Q70065279 | ||
| Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men | Q71125983 | ||
| Risk factors for restenosis after percutaneous transluminal coronary angioplasty: role of lipoprotein (a) | Q71550670 | ||
| Effects of lowering elevated LDL cholesterol on the cardiovascular risk of lipoprotein(a) | Q71588504 | ||
| Lipoprotein(a) induces cell growth in rat peritoneal macrophages through inhibition of transforming growth factor-beta activation | Q71592371 | ||
| Serum Lp(a) lipoprotein levels in patients with coronary artery disease and the influence of long-term n-3 fatty acid supplementation | Q71767728 | ||
| The serum concentration of active transforming growth factor-beta is severely depressed in advanced atherosclerosis | Q71802733 | ||
| Lipoprotein(a) in stored plasma samples and the ravages of time. Why epidemiological studies might fail | Q71930751 | ||
| Evaluation of lipoprotein (a) [Lp (a)] as a risk factor for coronary artery disease in the Turkish population | Q71939571 | ||
| Differences in lipoprotein (a) and apolipoprotein (a) levels in men and women with advanced coronary atherosclerosis | Q72011777 | ||
| Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study | Q72030504 | ||
| Evidence that apolipoprotein(a) phenotype is a risk factor for coronary artery disease in men < 55 years of age | Q72127538 | ||
| Nutrient intake and progression of coronary artery disease | Q72245713 | ||
| Lipoprotein(a) in restenosis after percutaneous transluminal coronary angioplasty and coronary artery disease | Q72344128 | ||
| Determinants of severity of coronary artery disease in Australian men and women | Q72415124 | ||
| A comparison of Lp(a) levels in fresh and frozen plasma using ELISAs with either anti-apo(a) or anti-apoB reporting antibodies | Q72428845 | ||
| Effectiveness of LDL-apheresis in preventing restenosis after percutaneous transluminal coronary angioplasty (PTCA): LDL-apheresis angioplasty restenosis trial (L-ART) | Q72428909 | ||
| Serum lipoprotein(a) and coronary artery disease in uremic patients on chronic hemodialysis | Q72431368 | ||
| Prevention of restenosis after percutaneous transluminal coronary angioplasty by reducing lipoprotein (a) levels with low-density lipoprotein apheresis. Low-Density Lipoprotein Apheresis Angioplasty Restenosis Trial (L-ART) Group | Q72485118 | ||
| P433 | issue | 2 | |
| P921 | main subject | coronary artery disease | Q844935 |
| P304 | page(s) | 333-345 | |
| P577 | publication date | 1998-12-01 | |
| P1433 | published in | Atherosclerosis | Q4813570 |
| P1476 | title | Lipoprotein(a) interactions with lipid and non-lipid risk factors in patients with early onset coronary artery disease: results from the NHLBI Family Heart Study | |
| P478 | volume | 141 |
| Q57605966 | Associations between classical cardiovascular risk factors and coronary artery disease in two countries at contrasting risk for myocardial infarction: the PRIME Study |
| Q34426054 | Asymmetric dimethylarginine potentiates lung inflammation in a mouse model of allergic asthma |
| Q26853571 | Benefits & risks of statin therapy for primary prevention of cardiovascular disease in Asian Indians - a population with the highest risk of premature coronary artery disease & diabetes |
| Q36593266 | Canadian Cardiovascular Society position statement--recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease |
| Q73965127 | Clinical implications of elevated lipoprotein(a) |
| Q45961438 | Comparison of different Lp (a) elimination techniques: a retrospective evaluation. |
| Q51559659 | Contribution of fasting hyperinsulinemia to prediction of atherosclerotic cardiovascular disease status in 293 hyperlipidemic patients. |
| Q33887894 | Epidemiology and prevention of coronary heart disease in families |
| Q31817214 | Lipoprotein (a) as a predictor of myocardial infarction in middle-aged men. |
| Q36877240 | Lipoprotein(a) Interactions With Low-Density Lipoprotein Cholesterol and Other Cardiovascular Risk Factors in Premature Acute Coronary Syndrome (ACS). |
| Q32054940 | Lipoprotein(a) further increases the risk of coronary events in men with high global cardiovascular risk |
| Q36368041 | Quo vadis haemapheresis. Current developments in haemapheresis |
| Q43927902 | Relation of lipoprotein(a) as coronary risk factor to type 2 diabetes mellitus and low-density lipoprotein cholesterol in patients > or =65 years of age (The Italian Longitudinal Study on Aging). |
| Q73118925 | The susceptibility of lipoprotein(a) to copper oxidation is correlated with the susceptibility of autologous low density lipoprotein to oxidation |
| Q37813833 | Vitamin D and cardiometabolic health: a review of the evidence |
Search more.